Pharmaceutical Analytical Testing Outsourcing Market Expanding At A CAGR 8.3% For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 3 March 2021: The Report Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing), By Region (North America, APAC), And Segment Forecasts, 2021 – 2028

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 12.4 billion by 2028 registering a CAGR of 8.3%, according to a new report by Grand View Research, Inc. Increasing pipelines for biological candidates along with rising demand for additional analytical details on drugs as well as process development by regulatory agencies are boosting the market growth. Analytical testing helps in providing real-time product quality control along with optimizing & monitoring processes, characterize biosimilar & biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to access skilled & experienced expertise, as well as expensive analytical equipment not available in-house.

Increasing R&D investments is one of the critical sustainability strategies. Not all companies have an infrastructure that is compatible with all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost. A patent cliff largely for small molecules with the pharmaceutical industry has led to a huge dent in the pharma’s profits. In the coming years, several best-selling drugs are coming towards the end of patent life including Humira. Drug innovators are under constant pressure to launch new products. Developing advanced analytical testing to assess & monitor the quality attributes of these requires a broader set of equipment & expertise, which is beyond the internal capacity of pharma companies.

The market is developing due to increasing competition in the pharmaceutical and biopharmaceutical markets for disease-specific drugs. Most pharmaceutical manufacturing companies rely on analytical testing to help and improve productivity, optimize and monitor processes, and offer real-time product quality control. Due to this, there is an increasing demand for analytical testing outsourcing services. Hence the market is expected to show lucrative growth over the forecast period. Outsourcing of analytical testing services allows companies to handle more complex activities and focus on their core competencies. This offers cost savings by letting medical companies evade building specialized facilities and hiring staff. Pharmaceutical analytical testing includes the identification and quantification of components in therapeutic solutions or drugs.

The nature of Covid-19 transmission has led several laboratory staff members to face uncertainties, such as fears of contracting the infection along with other biosafety concerns. Thus, reduced manpower and increasing focus on the development of vaccines & therapies against Covid-19 are anticipated to negatively impact the turnaround time for routine tests. The large number of R&D activities, clinical trials, and diagnostic procedures being conducted to counteract Covid-19 is anticipated to increase the demand for analytical testing services since several pharmaceutical companies are now focusing on their core competencies and outsourcing non-core functions to increase their productivity & operational efficiency.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

• The bioanalytical testing segment led the global market in 2020 accounting for the largest revenue share due to the high number of clinical trial registrations and entry of new participants within the market space
• The segment is also expected to register the fastest CAGR over the forecast period owing to growing R&D expenditure by pharmaceutical companies and preference for outsourcing bioanalytical testing
• The extractable and leachable services in the method development and validation segment is expected to dominate the market and register the fastest CAGR owing to an increasing number of vendors offering these services at competitive prices
• Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 due to low-cost service offering by the third-party service providers in the region

List of Key Players of Pharmaceutical Analytical Testing Outsourcing Market

• SGS SA
• Toxikon, Inc.
• Eurofins Scientific
• Pace Analytical Services, Inc.
• Intertek Group Plc
• Pharmaceutical Product Development, LLC.
• WuXi AppTec, Inc.
• Boston Analytical
• Charles River Laboratories International, Inc.
• West Pharmaceutical Services Inc.

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Expanding At A CAGR 8.3% For The Forecast Period From 2021 To 2028: Grand View Research Inc.

San Francisco, 27 Jan 2021: The Report Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing), By Region (North America, APAC), And Segment Forecasts, 2021 – 2028

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 12.4 billion by 2028 registering a CAGR of 8.3%, according to a new report by Grand View Research, Inc. Increasing pipelines for biological candidates along with rising demand for additional analytical details on drugs as well as process development by regulatory agencies are boosting the market growth. Analytical testing helps in providing real-time product quality control along with optimizing & monitoring processes, characterize biosimilar & biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to access skilled & experienced expertise, as well as expensive analytical equipment not available in-house.

Increasing R&D investments is one of the critical sustainability strategies. Not all companies have an infrastructure that is compatible with all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost. A patent cliff largely for small molecules with the pharmaceutical industry has led to a huge dent in the pharma’s profits. In the coming years, several best-selling drugs are coming towards the end of patent life including Humira. Drug innovators are under constant pressure to launch new products. Developing advanced analytical testing to assess & monitor the quality attributes of these requires a broader set of equipment & expertise, which is beyond the internal capacity of pharma companies.

The market is developing due to increasing competition in the pharmaceutical and biopharmaceutical markets for disease-specific drugs. Most pharmaceutical manufacturing companies rely on analytical testing to help and improve productivity, optimize and monitor processes, and offer real-time product quality control. Due to this, there is an increasing demand for analytical testing outsourcing services. Hence the market is expected to show lucrative growth over the forecast period. Outsourcing of analytical testing services allows companies to handle more complex activities and focus on their core competencies. This offers cost savings by letting medical companies evade building specialized facilities and hiring staff. Pharmaceutical analytical testing includes the identification and quantification of components in therapeutic solutions or drugs.

The nature of Covid-19 transmission has led several laboratory staff members to face uncertainties, such as fears of contracting the infection along with other biosafety concerns. Thus, reduced manpower and increasing focus on the development of vaccines & therapies against Covid-19 are anticipated to negatively impact the turnaround time for routine tests. The large number of R&D activities, clinical trials, and diagnostic procedures being conducted to counteract Covid-19 is anticipated to increase the demand for analytical testing services since several pharmaceutical companies are now focusing on their core competencies and outsourcing non-core functions to increase their productivity & operational efficiency.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

• The bioanalytical testing segment led the global market in 2020 accounting for the largest revenue share due to the high number of clinical trial registrations and entry of new participants within the market space
• The segment is also expected to register the fastest CAGR over the forecast period owing to growing R&D expenditure by pharmaceutical companies and preference for outsourcing bioanalytical testing
• The extractable and leachable services in the method development and validation segment is expected to dominate the market and register the fastest CAGR owing to an increasing number of vendors offering these services at competitive prices
• Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 due to low-cost service offering by the third-party service providers in the region

List of Key Players of Pharmaceutical Analytical Testing Outsourcing Market

• SGS SA
• Toxikon, Inc.
• Eurofins Scientific
• Pace Analytical Services, Inc.
• Intertek Group Plc
• Pharmaceutical Product Development, LLC.
• WuXi AppTec, Inc.
• Boston Analytical
• Charles River Laboratories International, Inc.
• West Pharmaceutical Services Inc.

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Size Is Projected To Reach USD 11.4 Billion By 2027: Grand View Research Inc.

The global pharmaceutical analytical testing outsourcing market is anticipated to be worth USD 11.4 billion by the year 2027, advancing at a CAGR of 8.3% during this period, according to a recent Grand View Research report. The growing expenditure on the research and development of pharmaceuticals is expected to provide a boost to the market growth. According to an EvaluatePharma report in 2018, the global R&D spending saw an increase of 3.9% in 2017 as compared to 2016, rising to USD 165 billion. The top 20 global pharma companies spent USD 97.2 billion in this area, with Roche leading the way.

There has been a rapid development of biosimilars and other such innovative medicines over the last few years, which has simultaneously increased the demand for particular types of pharmaceutical analytical tests. According to IQVIA, the total spending on biologics in the US was USD 125.5 billion in 2018, an increase of 9.5% from 2017. The spending on biosimilars had also doubled since 2017; however, it still represented only 2% of the US biologics market. This shows that there is a lot of space for development in this area.

Outsourcing has become a go-to option for many pharmaceutical companies, as it increases operational efficiency, provides access to therapeutic expertise, and benefit from on-demand services. Major outsourcing companies tend to look for acquisition of high impact service or manufacturing firms in order to enhance and boost their current capabilities. This is another factor for the market growth.

In terms of service, the market has been segmented into stability testing, bioanalytical testing, method development and validation. In addition, there are other testing services such as environmental monitoring, raw material testing, batch release, microbial testing, and physical characterization of materials. Bioanalytical testing services outsourcing is anticipated to show highest growth in the coming years, while the clinical bioanalytical testing segment is expected to lead the market through 2027, on account of the growing number of clinical trials, coupled with the presence of a strong regulatory framework.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Recent Developments in Pharmaceutical Analytical Testing Outsourcing Market

• With the uncontrolled growth of the coronavirus pandemic, Eurofins Scientific, in April 2020, announced the launch of a range of testing kits for serology-based antibody detection by ELISA of patients who have been exposed to COVID-19. The first ELISA assays are targeting the CE-IVD mark by 16 April 2020, and will also be submitted to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA).
• In April 2020, Accelerated Enrollment Solutions, a business unit of Pharmaceutical Product Development, LLC, announced a collaboration with Science 37, for recruiting and enrolling clinical trial participants who live beyond the geographic location of traditional research sites, while also working on providing telehealth support to remotely screen patients for coronavirus and conduct study visits. The patients can participate in AES studies through Science 37’s Metasite™.
• In August 2019, Boston Analytical opened an office in Cambridge for providing analytical testing as well as other services. The development comes on the back of the opening of a 30,000 square foot, state-of-the-art facility in Salem, NH in 2017, and the opening a 5,000 square foot laboratory specifically for its ever-growing protein characterization services in 2018.

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

Pharmaceutical Analytical Testing Outsourcing Market Size Is Projected To Reach USD 11.4 Billion By 2027: Grand View Research Inc.

San Francisco, 9 April 2020: The Report Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability, Method Development & Validation), By Region, And Segment Forecasts, 2020 – 2027

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 11.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.3% over the forecast period. Increasing pipelines for biological candidates, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth.

Analytical testing helps in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars and biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to benefit from skilled and experienced professionals, as well as to access expensive analytical equipment which are not available in-house.

Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have taken the center stage in the discovery and development of drugs. Moreover, there is a high demand to define higher-order biological structures. The need for better product characterization, along with comparability studies, especially for biosimilars, further leads to drug companies outsourcing these services.

A patent cliff, particularly for small molecules in the pharmaceutical industry leads to a decline in revenue, thereby affecting profits. Over the next few years, several best-selling biologics would come toward the end of patent life, such as Humira. Drug innovators are therefore under constant pressure to bring new products through the pipeline at a faster rate. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This would subsequently lead to increased instances of outsourcing pharmaceutical analytical testing services.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Further key findings from the report suggest:

• The outsourcing of clinical bioanalytical testing services emerged as the largest segment in 2019 with a share of around 79% owing to the increasing number of clinical trials
• The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices
• North America dominated the global market with a share of 54.2% in 2019 as the region is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals
• Some of the players operating in the pharmaceutical analytical testing outsourcing market are Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global pharmaceutical analytical testing outsourcing market on the basis of service and region:

Pharmaceutical Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2016 – 2027)

• Bioanalytical Testing
  • Clinical
  • Non Clinical
• Method Development & Validation
  • Extractable & Leachable
  • Impurity Method
  • Technical Consulting
  • Others
• Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability
  • Photostability
  • Others
• Others

Pharmaceutical Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2016 – 2027)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Pharmaceutical Analytical Testing Outsourcing Market Size Was Valued At USD 9.6 Billion By 2025: Grand View Research Inc.

San Francisco, 4 April 2019: The Report Pharmaceutical Analytical Testing Outsourcing Market Analysis By Services (Bioanalytical Testing, Method Development and Validation, Stability Testing), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025

The global Pharmaceutical Analytical Testing Outsourcing Market is expected to reach USD 9.6 billion by 2025, according to a new report by Grand View Research, Inc. The performance of market players in pharmaceutical analytical testing domain is highly influenced by the level of demand from end-user side. Due to intense market efforts, increasing awareness level, improving accessibility, and government initiatives, consumers, these days, are more concerned about self-care, resulting in higher consumption of pharmaceutical products.

The consumption levels are anticipated to rise exponentially over the forecast period. The companies and government organizations are working collaboratively to bridge the gap between supply and demand. As a result, companies have to realign their manufacturing capabilities to meet the increasing demand.

A major price difference between conducting analytical tests in-house and outsourcing has been observed. Companies may lack the required set-up and expertise to perform every possible test in-house. In addition, there are serval no routine activities that are needed to be performed only once. These include registration stability storage & testing, process & facility validation work, cleaning validations, analytical testing using expensive equipment & method development. For such tests, the best option is to outsource it to a specialty firm that has expertise and experience in this vertical. Outsourcing benefits companies with various aspects such as personnel management and reduction of equipment, validation & maintenance cost.

Access Research Report of Pharmaceutical Analytical Testing Outsourcing Market @ www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Further key findings from the study suggest:

• The other methods of validation services include cleaning validation services, analytical standard characterization, and peak identification. These services are anticipated to witness growth over the forecast period.
• Clinical bioanalytical testing market is likely to witness growth rate of over 8.0% during the forecast period owing to the increasing number of clinical trials coupled with a strengthened regulatory framework to perform drug discovery and development process at par with excellence.
• North America is expected to dominate the market at a global level owing to the better quality and propelling research activities being conducted within the region.
• Some of the key players in this market include SGS SA; Toxikon, Inc.; Eurofins Scientific; Pharmaceutical Product Development, LLC; Intertek Group plc; Pace Analytical Services, LLC; Exova Group plc; Boston Analytical; Charles River Laboratories International Inc.; and West Pharmaceutical Services, Inc. Regional & service portfolio expansions and merger & acquisitions are key strategic undertakings of these players.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global pharmaceutical analytical testing outsourcing market on the basis of services and region:

Pharmaceutical Analytical Testing Outsourcing Services Outlook (Revenue, USD Million, 2014-2025)

• Bioanalytical Testing
  • Clinical
  • Non Clinical
• Method Development & Validation
  • Extractable & Leachable
  • Impurity Method
  • Technical Consulting
  • Others
• Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Phostostability Testing
  • Others
• Others

Pharmaceutical Analytical Testing Outsourcing Services Regional Outlook (Revenue, USD Million, 2014-2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Access Press Release of Pharmaceutical Analytical Testing Outsourcing Market @  www.grandviewresearch.com/press-release/global-pharmaceutical-analytical-testing-outsourcing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com